Clinical Trial Update: Plasma and Abscess Fluid Pharmacokinetics of Cefpirome and Moxifloxacin After Single and Multiple Dose Administration [Phase 4]

View source ↗

Summary

Phase 4 trial updating the pharmacokinetics of cefpirome and moxifloxacin in plasma and abscess fluid after single and multiple doses.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Abscess
• Cysts

Drugs mentioned

• Cefpirome (cefpirome)
• Moxifloxacin (moxifloxacin)

Snippet

Sponsor: Medical University of Vienna | Conditions: Abscess, Cysts | Phase 4 | Status: COMPLETED